These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 8099977)

  • 1. Synthesis and opioid activity of dynorphin A-(1-13)NH2 analogues containing cis- and trans-4-aminocyclohexanecarboxylic acid.
    Snyder KR; Murray TF; DeLander GE; Aldrich JV
    J Med Chem; 1993 Jun; 36(13):1921-2. PubMed ID: 8099977
    [No Abstract]   [Full Text] [Related]  

  • 2. Synthesis and opioid activity of 2-substituted dynorphin A-(1-13) amide analogues.
    Story SC; Murray TF; Delander GE; Aldrich JV
    Int J Pept Protein Res; 1992 Aug; 40(2):89-96. PubMed ID: 1359999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and opioid activity of dynorphin A-(1-13)NH2 analogues containing cis- and trans-4-aminocyclohexanecarboxylic acid.
    Snyder KR; Murray TF; DeLander GE; Aldrich JV
    J Med Chem; 1993 Apr; 36(8):1100-3. PubMed ID: 8097539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological activity of [MeTyr1,MeArg7,D-Leu8]-dynorphin A(1-9)-NHEt and [D-Cys2-Cys5,MeArg7,D-Leu8]-dynorphin A(1-9)-NH2.
    Yoshino H; Arakawa Y; Nakazawa T; Kaneko T; Matsunaga M; Araki S; Ikeda M; Tsuchiya Y; Yamatsu K; Tachibana S
    Chem Pharm Bull (Tokyo); 1990 Aug; 38(8):2274-6. PubMed ID: 1980641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of modifications of residues in position 3 of dynorphin A(1-11)-NH2 on kappa receptor selectivity and potency.
    Lung FD; Meyer JP; Lou BS; Xiang L; Li G; Davis P; DeLeon IA; Yamamura HI; Porreca F; Hruby VJ
    J Med Chem; 1996 Jun; 39(13):2456-60. PubMed ID: 8691442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and synthesis of highly potent and selective cyclic dynorphin A analogues.
    Kawasaki AM; Knapp RJ; Kramer TH; Wire WS; Vasquez OS; Yamamura HI; Burks TF; Hruby VJ
    J Med Chem; 1990 Jul; 33(7):1874-9. PubMed ID: 1972964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, and biological properties of highly potent cyclic dynorphin A analogues. Analogues cyclized between positions 5 and 11.
    Meyer JP; Collins N; Lung FD; Davis P; Zalewska T; Porreca F; Yamamura HI; Hruby VJ
    J Med Chem; 1994 Nov; 37(23):3910-7. PubMed ID: 7966152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, and biological activities of cyclic lactam peptide analogues of dynorphine A(1-11)-NH2.
    Lung FD; Collins N; Stropova D; Davis P; Yamamura HI; Porreca F; Hruby VJ
    J Med Chem; 1996 Mar; 39(5):1136-41. PubMed ID: 8676350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and structure-activity relationships of dynorphin A-(1-8) amide analogues.
    Yoshino H; Nakazawa T; Arakawa Y; Kaneko T; Tsuchiya Y; Matsunaga M; Araki S; Ikeda M; Yamatsu K; Tachibana S
    J Med Chem; 1990 Jan; 33(1):206-12. PubMed ID: 1967312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-terminal alkylated derivatives of [D-Pro10]dynorphin A-(1-11) are highly selective for kappa-opioid receptors.
    Choi H; Murray TF; DeLander GE; Caldwell V; Aldrich JV
    J Med Chem; 1992 Nov; 35(24):4638-9. PubMed ID: 1361580
    [No Abstract]   [Full Text] [Related]  

  • 11. Synthesis and opioid activity of conformationally constrained dynorphin A analogues. 1. Conformational constraint in the "message" sequence.
    Arttamangkul S; Murray TF; DeLander GE; Aldrich JV
    J Med Chem; 1995 Jun; 38(13):2410-7. PubMed ID: 7608905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and structure-activity relationships of [MeTyr1, MeArg7]-dynorphin A(1-8)-OH analogues with substitution at position 8.
    Yoshino H; Kaneko T; Arakawa Y; Nakazawa T; Yamatsu K; Tachibana S
    Chem Pharm Bull (Tokyo); 1990 Feb; 38(2):404-6. PubMed ID: 1970951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of modification of the basic residues of dynorphin A-(1-13) amide on kappa opioid receptor selectivity and opioid activity.
    Snyder KR; Story SC; Heidt ME; Murray TF; DeLander GE; Aldrich JV
    J Med Chem; 1992 Nov; 35(23):4330-3. PubMed ID: 1360025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynorphin B-29: chemical synthesis and pharmacological properties in opioid systems in vitro.
    Sanchez-Blazquez P; Chang JK; Garzon J; Lee NM
    Neuropeptides; 1984 Sep; 4(5):369-74. PubMed ID: 6149489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N,N-diallyl-tyrosyl substitution confers antagonist properties on the kappa-selective opioid peptide [D-Pro10]dynorphin A(1-11).
    Gairin JE; Mazarguil H; Alvinerie P; Botanch C; Cros J; Meunier JC
    Br J Pharmacol; 1988 Dec; 95(4):1023-30. PubMed ID: 2905908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Highly kappa receptor-selective dynorphin A analogues with modifications in position 3 of dynorphin A(1-11)-NH2.
    Lung FD; Meyer JP; Li G; Lou BS; Stropova D; Davis P; Yamamura HI; Porreca F; Hruby VJ
    J Med Chem; 1995 Feb; 38(4):585-6. PubMed ID: 7861405
    [No Abstract]   [Full Text] [Related]  

  • 17. Irreversible blockade of the kappa-receptor by a newly synthesized dynorphin derivative containing a 3-nitro-2-pyridinesulfenyl group.
    Koike K; Takayanagi I; Hirakura Y; Matsueda R
    Arch Int Pharmacodyn Ther; 1991; 313():33-46. PubMed ID: 1687773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioid deltorphin C analogues containing cis- or trans-2- or 3- or 4-aminocyclohexanecarboxylic acid residues.
    Marastoni M; Guerrini R; Balboni G; Salvadori S; Fantin G; Fogagnolo M; Lazarus LH; Tomatis R
    Arzneimittelforschung; 1999 Jan; 49(1):6-12. PubMed ID: 10028372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N,N-diallylated analogs of dynorphin A-(1-13) as potent antagonists for the endogenous peptide and selective kappa opioid analgesics.
    Lemaire S; Parent P; Lapierre C; Michelot R
    Prog Clin Biol Res; 1990; 328():45-8. PubMed ID: 1968273
    [No Abstract]   [Full Text] [Related]  

  • 20. Kappa opioid properties of dynorphin and its peptide fragments on the guinea-pig Ileum.
    Yoshimura K; Huidobro-Toro JP; Lee NM; Löh HH; Way EL
    J Pharmacol Exp Ther; 1982 Jul; 222(1):71-9. PubMed ID: 6123594
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.